PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 28 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
In a double-blind crossover study of healthy volunteers, S. lateriflora significantly decreased Total Mood Disturbance scores compared to placebo, although no significant difference was found in Beck Anxiety Inventory (BAI) scores [PMID:23878109].
Safety & adverse effects
Evidence summary
PubMed sources
- 1.PMID: 31644066 (2012) — Herb-induced liver injury: Systematic review and meta-analysis. · CITED REFERENCE
- 2.PMID: 36055377 (2022) — Baicalein ameliorates cerebral ischemia-reperfusion injury by inhibiting ferroptosis via regulating GPX4/ACSL4/ACSL3 axis. · Chemico-biological interactions
- 3.PMID: 38495279 (2024) — Insights into skullcap herb-induced liver injury. · World journal of hepatology
- 4.PMID: 40205009 (2025) — Wogonin attenuates septic cardiomyopathy by suppressing ALOX15-mediated ferroptosis. · Acta pharmacologica Sinica
- 5.PMID: 38518646 (2024) — Baicalein improves the symptoms of polycystic ovary syndrome by mitigating oxidative stress and ferroptosis in the ovary and gravid placenta.